GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yungjin Pharm Co Ltd (XKRX:003520) » Definitions » Net Interest Income

Yungjin Pharm Co (XKRX:003520) Net Interest Income : ₩-2,864 Mil (TTM As of Dec. 2023)


View and export this data going back to 1973. Start your Free Trial

What is Yungjin Pharm Co Net Interest Income?

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. Yungjin Pharm Co's net interest income for the three months ended in Dec. 2023 was ₩-1,018 Mil. Its net interest income for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-2,864 Mil.

Yungjin Pharm Co Net Interest Income Historical Data

The historical data trend for Yungjin Pharm Co's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yungjin Pharm Co Net Interest Income Chart

Yungjin Pharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Interest Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -252.21 -250.67 -206.54 -733.87 -2,863.69

Yungjin Pharm Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -309.92 -613.14 -623.52 -609.37 -1,017.66

Yungjin Pharm Co Net Interest Income Calculation

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors.

Net Interest Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-2,864 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yungjin Pharm Co Net Interest Income Related Terms

Thank you for viewing the detailed overview of Yungjin Pharm Co's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Yungjin Pharm Co (XKRX:003520) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yungjin Pharm Co Ltd (XKRX:003520) » Definitions » Net Interest Income
Comparable Companies
XKRX:003000 XKRX:041960 XKRX:206640 XKRX:206650 XKRX:200670 XKRX:033270 XKRX:249420 XKRX:047920 XKRX:003220 XKRX:170900 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
Olympic-ro 35da-gil, Songpa-gu, (7-16, Shincheon-dong), 13, Seoul, KOR, 134-020
Website
http://www.yungjin.co.kr
Yungjin Pharm Co Ltd is a Korean pharmaceutical company. It manufactures and sales pharmaceutical goods in domestic and overseas markets. The firm's products are cephalosporin antibiotic, antipsychotic, cardiovascular, total nutrition, etc. It has manufacturing facilities located in Jenjou, Namyang, and Iksan in Korea.

Yungjin Pharm Co (XKRX:003520) Headlines

No Headlines